Drug recall · August 26, 2015
Lisinopril Tablets USP recall
Why: CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 94106 5, NDC 64679-941-06.
- Lots / codes
Lot #: DM13219, Exp 10/15; DM13428, Exp 11/15
- Quantity
- 3378 bottles
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- July 29, 2015 · Voluntary: Firm initiated
- Classified
- August 19, 2015
- Reported
- August 26, 2015
- Ended
- April 12, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.